As expected, A-485 preconditioning treatment significantly reduced protein Kla levels in 6 h ischemia brains (Figure 8A, B) without influencing the lactate production (Fig. S11C) and other PTMs levels, such as acetylation, succinylation, etc. (Fig. S11D-I). This evidence concerns the gene KL and ischemia.